Earnings Summary

Bioventus Inc’s revenue jumped 7.62% since last year same period to $135.42Mn in the Q4 2023. On a quarterly growth basis, Bioventus Inc has generated 12.11% jump in its revenue since last 3-months.

Bioventus Inc’s net profit jumped 86.41% since last year same period to $-6.1Mn in the Q4 2023. On a quarterly growth basis, Bioventus Inc has generated 16.53% jump in its net profits since last 3-months.

Bioventus Inc’s net profit margin jumped 87.38% since last year same period to -4.5% in the Q4 2023. On a quarterly growth basis, Bioventus Inc has generated 25.54% jump in its net profit margins since last 3-months.

Bioventus Inc’s earning per share (EPS) estimates for the current quarter stand at -0.07 - a -450% fall from last quarter’s estimates.

Bioventus Inc’s earning per share (EPS) estimates for the current year stand at -0.07.

Bioventus Inc’s earning per share (EPS) jumped 216.67% since last year same period to 0.07 in the Q4 2023. This indicates that the Bioventus Inc has generated 216.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bioventus Inc’s return on assets (ROA) stands at 0.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bioventus Inc’s return on equity (ROE) stands at -0.38.